Heterologous immunization with Covishield and Pfizer vaccines against SARS-CoV-2 elicits a robust humoral immune response

Heterologous immunization with Covishield and Pfizer vaccines against SARS-CoV-2 elicits a robust humoral immune response

Understanding the efficacy and durability of heterologous immunization schedules against SARS-CoV-2 is critical, as supply demands and vaccine choices become significant issues in the global vaccination strategy. Here we characterize the neutralizing antibodies produced in two subjects who received...

Full description

Saved in:
Bibliographic Details
Main Authors: Ali Toloue Ostadgavahi, Ryan Booth, Gary Sisson, Nichole McMullen, Michelle Warhuus, Peter Robertson, Matthew Miller, Wanda C Allen, May El Sherif, Robert Brownlie, Darryl Falzarano, Christopher D Richardson
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2021-05-01
Series:Journal of Infection in Developing Countries
Subjects:
SARS-CoV-2
COVID-19
heterologous immunization
humoral immunity
vaccines
neutralizing antibodies
Online Access:https://jidc.org/index.php/journal/article/view/15368
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jidc.org/index.php/journal/article/view/15368

Similar Items